Rigel Pharmaceuticals Inc. Q4 loss increases in line with estimates

(RTTNews) - Rigel Pharmaceuticals Inc. (RIGL) reported Loss for its fourth quarter that increased from last year in line with the Street estimates.

The company's earnings totaled -$22.64 million, or -$0.13 per share. This compares with -$19.24 million, or -$0.11 per share, in last year's fourth quarter.

Analysts on average had expected the company to earn -$0.13 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 10.6% to $20.41 million from $18.45 million last year.

Rigel Pharmaceuticals Inc. earnings at a glance (GAAP) :

-Earnings (Q4): -$22.64 Mln. vs. -$19.24 Mln. last year. -EPS (Q4): -$0.13 vs. -$0.11 last year. -Analyst Estimate: -$0.13 -Revenue (Q4): $20.41 Mln vs. $18.45 Mln last year.